Breaking News, Collaborations & Alliances

RVAC Medicines and A*STAR Sign Research Collaboration Agreement

Will jointly study and develop solutions to build mRNA manufacturing and analytics capabilities in Singapore.

Author Image

By: Charlie Sternberg

Associate Editor

RVAC Medicines Pte. Ltd., a messenger RNA (mRNA) technology platform company incubated by CBC Group, and the Agency for Science, Technology and Research (A*STAR) have signed a master research collaboration agreement to jointly study and develop solutions to build mRNA manufacturing and analytics capabilities in Singapore.   With this collaboration, RVAC and A*STAR will set up a joint laboratory based at A*STAR’s Bioprocessing Technology Institute (BTI) to develop a preclinical manufactur...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters